Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
Altium is under Algo Engine buy conditions. The share price is oversold and likely to rally from the current level.
A more conservative entry strategy will be to wait for the stochastic to turn higher or the price action to cross up through the 10-day average.
25/5 Since writing the above post in mid-May, ALU has rallied 20%. We anticipate a pick-up in earnings for the 6 month period ending June 30 and will be looking for confirmation that 2020 was an anomaly in the company’s growth trajectory.
Buy ALU with stops below $24.00
Qube Holdings is under Algo Engine buy conditions, with price support at $2.90. Consider a stop-loss on a break below the support.
In 2021, container port freight volumes are up on average 10 to 20% per month compared to last year.
25/5 Since writing the above post, QUB has found steady buying interest above the $2.90 support and the momentum indicators continue to trend higher.
A number of institutions have upgraded their price targets into the $3.40 to $3.60 range.
Macquarie Group is now under Algo Engine buy conditions following the recent price retracement from $162 down to $148.
Macquarie Group recently announced a net profit after tax attributable to ordinary shareholders of $3.01bn for the year ended 31 March 2021 (FY21), up 10 percent on the year ended 31 March 2020 (FY20).
Bega Cheese is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.
Accumulate within the $5.50 – $8.85 price range.
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
.
Zip Co is under Algo Engine buy conditions.
Zip Co will take full control of the UAE’s Spotii Holdings and Europe’s Twisto Payments for $160 million. Zip already has minority stakes in both businesses.
The transactions will help expand ZIP/’s global footprint.
Northern Star Resources is under Algo Engine buy conditions. The expected rally from sub $10 is now underway.
4/5 We again highlight Northern Star as our preferred gold play.
7/5
17/5 Buy NST within the $10.50 to $11.00 support range.
21/5 Buy NST
CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.
17/5 CURE is now experiencing an increase in buying interest and the stochastic short-term momentum indicator has turned higher.
ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.
21/5 Buy CURE
.
ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.
Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.
21/5 Buy IZZ
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453